DOI: 10.14704/nq.2016.14.2.943

A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects

Joseph A. Zamaria


This study is an examination of the positive and persisting psychological and behavioral aftereffects in eight individuals who reported consumption of psilocybin-containing mushrooms. Mushrooms containing psilocybin have been used for healing and spiritual purposes for thousands of years, and the therapeutic applications of psilocybin were scientifically examined beginning in the mid-20th century. Research from this era suggested that psilocybin was indicated as an effective adjunct to psychotherapy for conditions such as depression, anxiety, chemical dependency, and obsessive-compulsive disorder. Recent research at the Johns Hopkins School of Medicine demonstrated that participants who consumed psilocybin reported having profoundly meaningful experiences, and that these participants experienced persisting and positive changes to their mood, attitude, and behavior at 1-month and 14-month follow up. However, there has not yet been ample research examining the mechanism of the connection between participants’ experience with psilocybin and the existence of these positive and persisting aftereffects. This study employed a phenomenological approach, using an unstructured interview to gain an understanding of participants’ description of this mechanism. Eight adults were interviewed who reported using psilocybin in the past. A within-case analysis and cross-case analysis were conducted on the data, producing 11 themes within three categories: Set (which included the themes of Preliminary Anxiety and Substantial Preparation); Experience of Psilocybin Effect (which included the themes of Profound Shift in Attention, Unity Consciousness, Increased Introspection, Positive Emotional State, and Transcendental Experience); and Persisting Aftereffects (which included the themes of Short Term Reduction in Anxiety, Persisting Insight, Assistance with Psychological Distress, and Inspired Behavioral Change). Participants maintained insights gained during their experience of psilocybin far beyond the course of the substance. This research suggests that the positive and persisting aftereffects related to the consumption of psilocybin may be useful for psychological healing and growth, and that these aftereffects should continue to be studied.


psilocybin; psychology; positive; aftereffects; persisting; phenomenology; qualitative

Full Text:

Full Text PDF


Arfken ME. Political practice: A hermeneutic-phenomenological inquiry. Doctoral Dissertation, University of Tennessee, Knoxville, 2006.

Cohen WE and Inaba DS. Uppers, downers, all arounders: Physical and mental effects of psychoactive drugs. (5th ed.). Medford, OR: CNS Publications, Inc, 2004.

Creswell JW. Qualitative inquiry and research design: Choosing among five traditions. Thousand Oaks, CA: SAGE Publications, Inc., 1998.

Doblin R. Pahnke's "Good Friday experiment": A long-term follow-up and methodological critique. Journal of Transpersonal Psychology 1991; 23(1): 1-28.

Doblin R. Dr. Leary’s Concord prison experiment: A 34-year follow-up study. Journal of Psychoactive Drugs 1998; 30(4): 419-426.

Gasser P, Kirchner K and Passie T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology 2015; 29(1): 57-68.

Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U and Jesse R. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 2011; 218(4): 649-665.

Griffiths RR, Richards WA, Johnson MW, McCann UD and Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 2008; 22(6): 621-632.

Griffiths RR, Richards WA, McCann U and Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 2006; 187(3): 268-283.

Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL and Greer GR. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 2011; 68(1): 71-78.

Lester S. An introduction to phenomenological research. Taunton, UK: Stan Lester Developments, 1999.

MacLean KA, Johnson MW and Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology 2011; 25(11): 1453-1461.

McCracken G. The long interview (Vol. 13). Thousand Oaks, CA: SAGE Publications, 1988.

Moreno FA, Wiegand CB, Taitano EK and Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Journal of Clinical Psychiatry 2006; 67(11): 1735-1740.

Sessa B. Can psychedelics have a role in psychiatry once again? British Journal of Psychiatry 2005; 186: 457-458.

Sessa B. Shaping the renaissance of psychedelic research. The Lancet 2012; 380: 200-201.

Stafford, P. Psychedelics encyclopedia (3rd ed.). Berkeley, CA: Ronin Publishing, Inc, 1992.

Strassman RJ. Adverse reactions to psychedelic drugs: A review of the literature. The Journal of Nervous and Mental Disease 1984; 172(10); 577-595.

Studerus E, Gamma A, Kometer M and Vollenweider FX. (2012). Prediction of psilocybin response in healthy volunteers. PLoS ONE 2012; 7(2): e30800.

Supporting Agencies

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

| NeuroScience + QuantumPhysics> NeuroQuantology :: Copyright 2001-2019